Published in Acta Paediatr Scand on July 01, 1981
A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A. Haematologica (2011) 0.86
Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method. Biologics (2014) 0.83
IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia. J Thromb Haemost (2013) 0.80
Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med (1992) 3.21
Molecular pathology of haemophilia B. EMBO J (1989) 2.74
Number of projections in mammography: influence on detection of breast disease. AJR Am J Roentgenol (1978) 2.44
A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med (1994) 2.22
Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis? Am J Obstet Gynecol (1989) 2.06
Magnetic resonance imaging of the musculoskeletal system. Acta Radiol Diagn (Stockh) (1985) 2.06
Thromboembolic disease--critical evaluation of laboratory investigation. Thromb Haemost (1992) 1.93
Fibrinolytic activity of human veins. Lancet (1967) 1.91
Hematogenous infection in total joint replacement. Clin Orthop Relat Res (1979) 1.89
AHF related protein in clinical praxis. Scand J Haematol (1974) 1.78
Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol (1995) 1.77
Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis. Acta Chir Scand (1972) 1.74
The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots. Nucleic Acids Res (1990) 1.64
Association between lactate in vaginal fluid and time to spontaneous onset of labour for women with suspected prelabour rupture of the membranes. BJOG (2006) 1.64
Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol) (1980) 1.64
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med (1999) 1.61
Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood (1992) 1.61
Bone cement, thermal injury and the radiolucent zone. Acta Orthop Scand (1984) 1.61
A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res (1980) 1.59
Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B. J Thromb Haemost (2007) 1.56
Comparative cytotoxicity of deoxynivalenol, nivalenol, their acetylated derivatives and de-epoxy metabolites. Food Chem Toxicol (2004) 1.55
Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study. J Rheumatol (1988) 1.53
Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma. Thromb Haemost (1991) 1.53
Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate. Lancet (1990) 1.53
Compatible scales for progressive and additive MRI assessments of haemophilic arthropathy. Haemophilia (2005) 1.52
Intrauterine death and circulating anticoagulant ("antithromboplastin"). Acta Med Scand (1975) 1.51
A nascent secretory protein may traverse the ribosome/endoplasmic reticulum translocase complex as an extended chain. J Biol Chem (1996) 1.51
Metabolism of aflatoxin, ochratoxin, zearalenone, and three trichothecenes by intact rumen fluid, rumen protozoa, and rumen bacteria. Appl Environ Microbiol (1984) 1.48
Determination of plasminogen in clots and thrombi. Thromb Diath Haemorrh (1966) 1.48
Coagulation and fibrinolytic studies during pregnancy. Acta Obstet Gynecol Scand (1967) 1.48
Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol (1975) 1.47
HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis--their relation to disease progression. J Rheumatol (1993) 1.46
Haemophilia prophylaxis in Sweden. Acta Paediatr Scand (1976) 1.46
Haemophilia prophylaxis in young patients--a long-term follow-up. J Intern Med (1997) 1.44
Intravascular coagulation and acute renal failure in a child with mycoplasma infection. Acta Med Scand (1971) 1.44
Influence of aprotinin, a protease inhibitor, on porcine E. coli shock. Studies on coagulation, fibrinolytic and hemodynamic response. Acta Chir Scand (1989) 1.42
Early rheumatoid arthritis--onset, course, and outcome over 2 years. Rheumatol Int (1990) 1.41
Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes. J Nucl Cardiol (2000) 1.40
Comparison of two surgical methods for treatment of crib-biting in horses. Equine Vet J (1992) 1.39
[Threatened future of plasma products. Who is responsible?]. Lakartidningen (1996) 1.39
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease. Proc Natl Acad Sci U S A (1989) 1.35
The subcellular distribution and properties of aldehyde dehydrogenases in rat liver. Biochem J (1973) 1.32
Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells. Biochemistry (1988) 1.32
The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology (1998) 1.30
Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haematol (1965) 1.29
Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis. Lancet (1985) 1.28
Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa). J Thromb Haemost (2009) 1.27
Two genetic variants of von Willebrand's disease. N Engl J Med (1973) 1.25
Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis. Ann Rheum Dis (1988) 1.25
[Risk of thromboembolism with oral contraceptives]. Lakartidningen (1967) 1.23
Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC). J Clin Invest (1982) 1.23
The 1.8 A crystal structure of the dimeric peroxisomal 3-ketoacyl-CoA thiolase of Saccharomyces cerevisiae: implications for substrate binding and reaction mechanism. J Mol Biol (1997) 1.22
Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology (1997) 1.21
Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthop Scand Suppl (1965) 1.19
Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J (Clin Res Ed) (1985) 1.19
Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. N Engl J Med (1983) 1.18
Radiographic measurements of the cranio-vertebral region. Designed for evaluation of abnormalities in rheumatoid arthritis. Acta Radiol Diagn (Stockh) (1984) 1.18
Is running associated with degenerative joint disease? JAMA (1986) 1.18
Staging of intraosseous extent of osteosarcoma: correlation of preoperative CT and MR imaging with pathologic macroslides. Radiology (1988) 1.17
Presentation and evaluation of a new optical sensor for respiratory rate monitoring. Int J Clin Monit Comput (1994) 1.16
Metabolism of zearalenone in rat liver. Acta Pharmacol Toxicol (Copenh) (1978) 1.15
Recurrent and non-recurrent dislocation following total hip arthroplasty. Acta Orthop Scand (1982) 1.15
Coagulation and fibrinolytic studies during use of gestagens. Acta Obstet Gynecol Scand (1967) 1.14
Catheter material and blood coagulation studies in vitro. Scand J Haematol (1969) 1.13
CT scans and lipohaemarthrosis in hip fractures. J Bone Joint Surg Br (1990) 1.12
Fibrinolysis in newborns. Acta Paediatr Scand (1970) 1.12
High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. Br J Haematol (2001) 1.12
Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors. J Clin Invest (1983) 1.12
New aspects of the pathogenesis of thrombo-embolism. Prog Surg (1973) 1.11
Breast cancer screening with mammography: a population-based, randomized trial with mammography as the only screening mode. Radiology (1979) 1.11
Severe asphyxia due to delivery-related malpractice in Sweden 1990-2005. BJOG (2008) 1.11
Clinical experience with determination of fibrinogen degradation products. Acta Med Scand (1971) 1.10
Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy. Lancet (1988) 1.09
Fibrin degradation products and ovarian tumours. Br Med J (1971) 1.08
Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg. Acta Chir Scand (1970) 1.08
Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor. Ann Rheum Dis (1990) 1.08
Thrombosis and oral contraceptives: possible predisposition. Br Med J (1973) 1.07
Coagulation and fibrinolytic studies during continuous use of low dose gestagen. Acta Endocrinol (Copenh) (1970) 1.07
Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX. Scand J Haematol (1976) 1.06
Shelf-life of bank blood and stored plasma with special reference to coagulation factors. Transfusion (1983) 1.06
"Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms. Acta Chir Scand (1972) 1.05
Binding of delta-1-tetrahydrocannabinol to human plasma proteins. Biochem Pharmacol (1970) 1.05
Primary musculoskeletal tumors: examination with MR imaging compared with conventional modalities. Radiology (1987) 1.04
Value of streptokinase and heparin in treatment of acute deep venous thrombosis. A coded investigation. Acta Chir Scand (1968) 1.04
Myelography in the elderly and the diagnosis of spinal stenosis. Spine (Phila Pa 1976) (1985) 1.04
Genetic variants of von Willebrand's disease. Br Med J (1972) 1.03